During the scientific trial knowledge with Xyrem in narcolepsy/cataplexy patients at therapeutic doses, two people documented stress and 1 described sleeplessness next abrupt discontinuation with the termination of your clinical demo; in The 2 individuals with stress, the frequency of cataplexy had enhanced markedly concurrently.And also featuring